Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement

被引：2

作者：

Lionel, Anath C. ^{[1
]}

Gurumurthi, Ashwath ^{[1
]}

Fetooh, Ahmed ^{[1
]}

Eldaya, Rami ^{[2
]}

Ahmed, Sairah ^{[1
]}

Iyer, Swaminathan P. ^{[1
]}

Nastoupil, Loretta J. ^{[1
]}

Westin, Jason ^{[1
]}

Nair, Ranjit ^{[1
]}

Fayad, Luis ^{[1
]}

Malpica, Luis ^{[1
]}

Tummala, Sudhakar ^{[3
]}

Flowers, Christopher ^{[1
]}

Neelapu, Sattva S. ^{[1
]}

Wang, Michael L. ^{[1
]}

Jain, Preetesh ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, 1515 Holcombe Blvd, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Neuroradiol, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA

来源：

LEUKEMIA & LYMPHOMA | 2024年 / 65卷 / 05期

关键词：

D O I：

10.1080/10428194.2024.2304622

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：669 / 673

页数：5

共 50 条

[1] Bridging Radiotherapy prior to Brexucabtagene Autoleucel CAR T-Cell Therapy in Mantle Cell Lymphoma
Figura, N.
Sim, A.
Dahiya, S.
Lutfi, F.
Rapoport, A.
Mohindra, P.
Dohm, A.
Chavez, J.
Shah, B.
Khimani, F.
Lazaryan, A.
Davila, M.
Bachmeier, C.
Nishihori, T.
Liu, H.
Kim, S.
Locke, F.
Jain, M.
Robinson, T.
RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S894 - S895
[2] Brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma
Mian, Agrima
Hill, Brian T.
EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 435 - 441
[3] Brexucabtagene Autoleucel: A Novel Chimeric Antigen Receptor T-cell Therapy for the Treatment of Mantle Cell Lymphoma
Anderson, Mary Kate
Torosyan, Annie
Halford, Zachery
ANNALS OF PHARMACOTHERAPY, 2022, 56 (05) : 609 - 619
[4] CAR T-cell therapy for mantle cell lymphoma with central nervous system relapse
Vu, Khoan
Frank, Matthew J.
BLOOD ADVANCES, 2023, 7 (03) : 375 - 378
[5] Real-world experience with CAR-T therapy with Brexucabtagene Autoleucel for advanced relapsed mantle cell lymphoma
Heini, A.
Kronig, M. -N.
Bacher, U.
Taleghani, B. Mansouri
Novak, U.
Pabst, T.
SWISS MEDICAL WEEKLY, 2021, 151 : 2 - 2
[6] Clinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvement
Ryan, Christine E.
Zon, Rebecca L.
Redd, Robert
Fisher, David C.
Shouval, Roni
Kumar, Anita
Crombie, Jennifer L.
Sadrzadeh, Hossein
Kim, Austin I.
Nayak, Lakshmi
Chukwueke, Ugonma N.
Jacobson, Caron A.
Frigault, Matthew J.
Palomba, M. Lia
Armand, Philippe
Epstein-Peterson, Zachary
Merryman, Reid W.
BRITISH JOURNAL OF HAEMATOLOGY, 2023, 203 (05) : 774 - 780
[7] Efficacy and Safety of Sequential Different B Cell AntigenTargeted CAR T-Cell Therapy for Pediatric Refractory/Relapsed Burkitt Lymphoma with Secondary Central Nervous System Involvement
Liu, Ying
Deng, Biping
Hu, Bo
Zhang, Wenqun
Zhu, Qing
Liu, Yang
Wang, Shan
Zhang, Pei
Yang, Junhan
Zheng, Qinglong
Yu, Xinjian
Gao, Zifen
Zhou, Chunju
Han, Wei
Chang, Alex Hong
Zhang, Yonghong
BLOOD, 2021, 138
[8] CAR T-cell Therapy for Central Nervous System Lymphoma
Houillier, Caroline
Choquet, Sylvain
CURRENT ONCOLOGY REPORTS, 2024, 26 (11) : 1521 - 1529
[9] BTK Inhibitors and CAR T-Cell Therapy in Treating Mantle Cell Lymphoma—Finding a Dancing Partner
Javier L. Munoz
Yucai Wang
Preetesh Jain
Michael Wang
Current Oncology Reports, 2022, 24 : 1299 - 1311
[10] Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma: Real World Experience from the US Lymphoma CAR T Consortium
Wang, Yucai
Jain, Preetesh
Locke, Frederick L.
Munoz, Javier
Maurer, Matthew J.
Beitinjaneh, Amer
Frank, Matthew J.
Dahiya, Saurabh
McGuirk, Joseph P.
Jacobs, Miriam T.
Goy, Andre H.
Vose, Julie M.
Hill, Brian T.
Oluwole, Olalekan O.
Deol, Abhinav
Shah, Bijal D.
Paludo, Jonas
Wang, Trent
Lekakis, Lazaros J.
Miklos, David B.
Rapoport, Aaron P.
Ghobadi, Armin
Neelapu, Sattva S.
Lin, Yi
Wang, Michael
Jain, Michael D.
BLOOD, 2021, 138

← 1 2 3 4 5 →